Revision as of 16:23, 7 April 2015 by Turky Alkathery (talk | contribs) (Created page with "{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 447822894 | IUPAC_name = N-(2-hydroxyethyl)-3-phenyl-2-propenamide | image...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Clinical data
Trade namesTalval, Srilane, Relaxnova, Brolitène
AHFS/Drugs.comInternational Drug Names
Routes of
ATC code
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Molar mass191.226 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Idrocilamide (trade names Talval, Srilane, Relaxnova, Brolitène[1][2]) is a medication with skeletal muscle relaxant[3] and anti-inflammatory actions[4] used as a topical cream to treat lumbago and other kinds of muscular pain;[5] it is available on prescription or over-the-counter[citation needed] in France and various other countries.[1]


Idrocilamide has been reported to be a potent inhibitor of the metabolism of caffeine.[6][7]


  1. 1.0 1.1 International Drug Names
  2. Idrocilamide
  3. PMID 2085796 (PMID 2085796)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
  4. Bannwarth B, Le Huec JC, Vinçon G; et al. (December 1993). "[Tissue and systemic diffusion of idrocilamide after cutaneous administration]". Rev Rhum Ed Fr (in French). 60 (12): 932–6. PMID 8012322.
  5. PMID 2140002 (PMID 2140002)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
  6. Carrillo JA, Benitez J (August 2000). "Clinically significant pharmacokinetic interactions between dietary caffeine and medications". Clin Pharmacokinet. 39 (2): 127–53. doi:10.2165/00003088-200039020-00004. PMID 10976659.
  7. Brazier JL, Descotes J, Lery N, Ollagnier M, Evreux JC (January 1980). "Inhibition by idrocilamide of the disposition of caffeine". Eur. J. Clin. Pharmacol. 17 (1): 37–43. doi:10.1007/bf00561675. PMID 7371698.